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Platelet-activating factor (PAF) stimulates glycogenolysis n perfused livers but not in isolated hepatocytes [(1984) J. Biol. 
Chem. 259, 8685586881. PAF-induced glycogenolysis n liver is associated closely with a pronounced constriction of the 
hepatic vasculature [(1986) J. Biol. Chem. 261,644-649]. These and other observations uggest that PAF stimulates glyco- 
genolysis in liver indirectly by interactions with cells other than hepatocytes. We have evaluated effects of PAF on hepatic 
Kupffer cells, which regulate flow through the hepatic sinusoids. Application of PAF to PH]inositol-labeled Kupffer cells 
produced dose-dependent increases in PH]inositol phosphates with an EC,, value of 4 x lo-i0 M. Increases in inositol 
phosphate production in response to PAF were inhibited by a specific PAF receptor antagonist, SRI 63-675 (2 x lo-’ 
M), and stimulus of protein kinase C, phorbol 12-myristate 13-acetate (1 x IO-’ M). Measurements of cytosolic free Ca2+ 
concentrations ([Caz’],) in single Kupffer cells loaded with Fura- demonstrated that application of PAF (2 x low9 M) 
resulted in significant increases in [Ca2’li. These observations lead us to propose that interactions of PAF with Kupffer 
cells may result in the hemodynamic and metabolic responses to PAF in liver. 
Platelet-activating factor; Phospholipase C; Inositol phosphate; Ca*+; (Liver, Kupffer cell) 
1. INTRODUCTION 
PAF (I-0-alkyl-2-acetyl-sn-glycero-3-phospho- 
choline) is a unique phospholipid mediator which 
exerts potent glycogenolytic actions in perfused rat 
livers by mechanisms distinct from a-adrenergic 
agents or glucagon [l-6]. Most notable among the 
differences between PAF and these other glyco- 
genolytic agents is the absence of glycogenolytic ac- 
tions of PAF in isolated hepatocytes [2], the princi- 
ple storage site for glycogen in liver. Interestingly, 
PAF stimulates degradation of phosphatidyl- 
inositol bisphosphate in hepatocytes without con- 
sequent production of inositol trisphosphate or 
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Ca2+ mobilization [2,6,7]. This apparent enigma 
appears due to degradation of phosphoinositides 
by phospholipase AS following exposure of hepato- 
cytes to PAF [8]. Associated with the glycogeno- 
lytic effect of PAF in perfused livers is a pronounc- 
ed constriction of the hepatic vasculature resulting 
in several metabolic alterations consistent with 
ischemia within hepatic sinusoids [1,3,9]. It is well 
known that ischemia causes glycogenolysis in liver 
[lo]. Thus, we have suggested that hepatocytes are 
not the primary site of action of PAF in the liver 
and that glycogenolysis in response to this lipid 
mediator is a result of interactions with the hepatic 
vasculature leading to vasoconstriction [3,4]. This 
concept is supported by the absence of glycogeno- 
lytic responses to pathophysiological concentra- 
tions of PAF in retrograde-perfused livers and liver 
slices as well as localization studies demonstrating 
that [3H]PAF binds exclusively to periportal 
sinusoidal cells and not hepatocytes upon infusion 
into perfused livers [ 111. 
It seemed entirely appropriate to investigate 
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agonist properties of PAF in hepatic Kupffer cells, 
which act as sphincters to regulate flow through the 
hepatic sinusoids [12]. Observations in the per- 
fused liver indicate that biological responses to 
PAF may involve mobilization of Ca2+ from a 
small non-hepatocyte pool [ 131 and Ca2+ mobiliza- 
tion is an important signalling mechanism by which 
various hormones and mediators regulate cell func- 
tion. Moreover, it is now well accepted that metab- 
olism of inositol phospholipids can lead to the 
generation of second messengers which regulate 
[Ca2+]i [141. In the present communication we have 
performed experiments to explore agonist effects 
of PAF on inositol lipid hydrolysis and [Ca2+]i in 
hepatic Kupffer cells. These studies provide the 
first evidence that PAF exerts agonist effects on 
Kupffer cells at concentrations comparable to 
those producing biological responses in liver. 
2. MATERIALS AND METHODS 
2.1. Materials 
PAF (l-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine) 
and lyso-PAF (I-O-hexadecyl-sn-glycero-3-phosphocholine) 
were purchased from Bachem. myo-[2-‘H]Inositol was obtained 
from Amersham. SRI 63-675 was kindly provided by Dr Dean 
Handley, Sandoz Research Institute. All other chemicals were 
obtained from Sigma. 
2.2. Kupffer cell culture 
Kupffer cells were isolated from livers of male Sprague- 
Dawley rats (200-250 g) employing previously described 
methods [ 151. Briefly, livers were digested by collagenase/pro- 
nase perfusion and sinusoidal cells were purified by centrifuga- 
tion on a metrizamide gradient. Cells were cultured in Ml99 
containing 10% fetal bovine serum (4 x lo6 cells/35 mm 
culture dish) at 37°C in a 5% CO2 atmosphere. Culture medium 
was replaced after overnight incubation resulting in the removal 
of non-adherent endothelial cells [16] and cultures were used for 
experiments 1 to 5 days after plating. The purity of these Kupf- 
fer cell cultures was 90-95% as assessed by positive peroxidase 
staining, in agreement with previous histochemical as well as 
morphological and functional characterizations of these 
cultures [15,16]. For measurements of [Ca’+]r in single Kupffer 
cells, Kupffer cells were cultured on 25 mm glass coverslips. As 
with plastic culture dishes, Kupffer cells but not endothelial cells 
attached to the glass surface [16]. 
2.3. Incubations and analyses 
All studies of inositol phosphate production in Kupffer cells 
were performed at 37°C. For labeling inositol lipids, cultures 
were incubated 20-24 h in serum-free Ml99 containing myo- 
[2-‘Hlinositol (l-2 pCi/ml). Cultures were rinsed and incubated 
in BSS for 60 min and then rinsed and incubated 15 min in BSS 
containing 5 mM LiCl prior to addition of PAF and other 
agents (time 0). Incubations were terminated 30 min following 
agonist addition by removing the medium and adding 1 ml of 
ice-cold methanol. Inositol phosphates were extracted by addi- 
tion of 1.5 ml of chloroform: water (2: 1) and samples of the 
aqueous phase were analyzed for total labeled inositol phos- 
phates by batch elution from Dowex columns as described by 
Brown et al. [17]. 
[Ca”]i was measured in individual Kupffer cells using fluo- 
rescent videomicroscopy and digital image analysis of Fura-2- 
loaded cells as described by Sharma and Bhalla [ 181. These ex- 
periments were performed with 3 day cultures following incuba- 
tion in serum-free Ml99 for 20-24 h. Kupffer cells were loaded 
with Fura- by incubation with Fura_2/acetoxymethyl ester 
(5 x 10m6 M) for 45 min at 37°C and then incubated an addi- 
tional 30 min in BSS at 37°C. 
Results are expressed as means + SE. Significance of dif- 
ferences between samples was assessed using analysis of 
variance and Sheffe’s post hoc analysis. 
3. RESULTS 
Fig.1 illustrates the effect of PAF on inositol 
phosphate production in [3H]inositol-labeled 
Kupffer cell cultures. Exposure of Kupffer cells to 
PAF (1 x 10m9 M) resulted in a significant increase 
(gcO.01) in inositol phosphate production which 
was not observed in response to a 200-fold higher 
concentration of lyso-PAF. Incubation with vehi- 
cle (saline) alone did not increase [3H]inositol phos- 
phates in Kupffer cells above values observed at 
time 0. 
Stimulation of Kupffer cell inositol phosphate 
production by PAF was dose-dependent with half- 
maximal responses occurring at approximately 
4 x lo-” M PAF (fig.2). The exquisite sensitivity 
of Kupffer cells to PAF can be appreciated by the 
small but significant (pcO.05) increase in inositol 
phosphate production observed in response to 
1 x lo-” M PAF. Maximal responses to PAF were 
apparent at 3 x 1O-9 M. At maximal concentra- 
tions, PAF increased [3H]inositol phosphates in 
Kupffer cells over 700% compared to either saline 
or time 0 (not shown) values. Preliminary ex- 
periments employing HPLC separation of inositol 
phosphates have shown that increases in radioac- 
tivity in inositol 1,4,5trisphosphate are apparent 
in Kupffer cells stimulated with PAF (2 x 10m9 M) 
for 15 s (not shown). 
Activation of platelets by PAF can be inhibited 
by PAF receptor antagonists and activators of pro- 
tein kinase C [19-211. Activation of protein kinase 
C inhibits receptor-stimulated phospholipase C in a 
variety of cells and may represent an important 
feedback mechanism for regulating receptor re- 
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Fig.1. Effect of PAF on inositol phosphate production in 
cultured rat Kupffer cells. Kupffer cells were incubated with 
saline, lyso-PAF (2 x lo-’ M) or PAF (1 x 10e9 M) for 30 min 
before termination of incubation and measurement of inositol 
phosphates as described under section 2. Values shown repre- 
sent means f SE (n = 3). 
sponses [14]. To characterize PAF receptor re- 
sponses in Kupffer cells further, PAF-stimulated 
inositol phosphate production was evaluated in the 
presence of a PAF receptor antagonist (SRI 
63-675) [22] and activator of protein kinase C 
(PMA). Fig.3 shows that PAF-stimulated inositol 
phosphate production in Kupffer cells was reduced 
to approximately 10% and 35% of control values 
by SRI 63-675 (2 x IO-’ M) and PMA 
(1 x lo-’ M), respectively. Interestingly, incuba- 
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Fig.2. Dose response of PAF on inositol phosphate production 
in cultured rat Kupffer cells. Kupffer cells were incubated with 
saline or various concentrations of PAF for 30 min before ter- 
mination of incubation and measurement of inositol phosphates 
as described under section 2. Values shown represent means k 
SE (n = 3). 
Fig.3. Effects of SRI 63-675 and PMA on PAF-stimulated in- 
ositol phosphate production in cultured rat Kupffer cells. SRI 
63-675 (2 x lo-’ M) and PMA (1 x 10m7 M) were added to 
Kupffer cells 15 min prior to addition of saline or PAF 
(2 x low9 M) for 30 min. Incubations and inositol phosphate 
measurements were performed as described under section 2. 
Values shown represent means of duplicate experiments. 
tion of Kupffer cells with PMA produced increases 
in [3H]inositol phosphates of approximately 100%. 
Similar results have been reported in MDCK cells 
where PMA increased basal levels of inositol 
monophosphate but inhibited receptor-mediated 
production of inositol phosphates [23]. 
In view of our findings that PAF receptors are 
coupled to activation of phosphoinositide phos- 
pholipase C in Kupffer cells, preliminary ex- 
periments were performed to evaluate effects of 
PAF on [Ca’+]i in Kupffer cells. [Ca’+]i in un- 
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Fig.4. Effect of PAF on [Ca*+]i in an individual rat Kupffer cell. 
PAF was added to the microscope chamber at time 0 as an equal 
volume addition to provide a final PAF concentration of 
2 x 10e9 M. [Ca*+]i was measured as described under section 2. 
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stimulated Kupffer cells averaged 62 + 8 nM 
(n = 12). Fig.4 illustrates a representative ffect of 
PAF (2 x 10m9 M) on [Ca’+]r in a single Kupffer 
cell. Although maximal increases in [Ca2+]i in re- 
sponse to PAF exposure were apparent at the first 
sampling period (10 s) in some cells, typically there 
was a delay as shown in fig.4. These variations 
were observed even with different cells on the same 
coverslip suggesting some cell-cell variability in re- 
sponses to PAF. After the peak increase in [Ca’+]i 
was attained, [Ca’+]i decreased to a level which re- 
mained elevated above basal values for the dura- 
tion of our experiments (3 min). In 7 individual 
cells, exposure to PAF increased [Ca2+]i to 
118 + 23 nM (p<O.Ol). 
4. DISCUSSION 
The data presented in this report provide the first 
demonstration that Kupffer cells respond to bio- 
logically-relevant concentrations of PAF and that 
this response involves activation of phospho- 
inositide phospholipase C and increases in [Ca”]i. 
Phospholipase C responses to PAF in Kupffer cells 
occurred at low molar concentrations of PAF but 
not the biologically inactive form of PAF (lyso- 
PAF) and were prevented by a specific PAF recep- 
tor antagonist. These observations suggest that 
PAF interacts with specific receptors in Kupffer 
cells to regulate inositol phosphate production. 
It is important to consider the relationship be- 
tween the present results and the biological actions 
of PAF in liver. We have suggested that the potent 
glycogenolytic actions of PAF in perfused livers 
are secondary to PAF-induced constriction of the 
hepatic sinusoids [3,4]. Implicit in this hypothesis 
are the requirements that PAF does not produce 
direct glycogenolytic effects in hepatocytes and 
that primary interactions of PAF occur with cells 
regulating flow through the hepatic sinusoids. In 
keeping with these criteria, PAF has no effects on 
glycogenolysis in freshly isolated hepatocytes, 
cultured hepatocytes or liver slices [2,6,11]. More- 
over, this study has demonstrated primary effects 
of PAF on Kupffer cells, cells which restrict blood 
flow by acting as ‘sphincters’ in the hepatic 
sinusoids [12]. The effects of PAF on Kupffer cells 
described in this study occurred at PAF concentra- 
tions comparable to those producing glycogeno- 
lysis and vasoconstriction in perfused rat livers, 
i.e., 2 x lo-” to 2 x 10e9 M [3,4]. EC& values for 
these effects of PAF in perfused livers 
(-2 x lo-” M) [4] are very similar to values 
observed in this study for effects of PAF on Kupf- 
fer cell inositol phosphate production. These 
observations upport the concept that Kupffer cells 
are a primary site of PAF action in liver. 
Recently, Kuiper et al. [24] reported that PAF 
stimulates production of prostaglandin Dz from 
Kupffer cells. These authors demonstrated that 
prostaglandin D2 increases glycogenolysis in 
hepatocytes and perfused livers and suggested that 
PAF stimulates glycogenolysis in liver indirectly by 
stimulation of Kupffer cell prostaglandin D2 pro- 
duction. However, PAF stimulated prostaglandin 
Dz production in Kupffer cells only at concentra- 
tions greater than 1 x lo-* M. Because PAF 
stimulates glycogenolysis and vasoconstriction in 
perfused livers at much lower concentrations their 
results suggest, to the contrary, that Kupffer cell- 
derived prostaglandin Da is not involved in hepatic 
responses to pathophysiological concentrations of 
PAF. Recently, Lapointe and Olson (personal 
communication and [25]) demonstrated that low 
concentrations of indomethacin or ibuprofen could 
be used to completely block prostaglandin DZ and 
thromboxane A2 production in perfused livers 
without inhibiting glycogenolytic and hemo- 
dynamic responses to PAF. In view of these obser- 
vations and the absence of glycogenolytic re- 
sponses to PAF (1 x lo- 9 M) in liver slices and 
retrograde-perfused livers [ 1 I], it seems unlikely 
that hepatic responses to PAF are secondary to the 
production of Kupffer cell mediators. However, a 
possible autocrine role of PAF in regulating Kupf- 
fer cells is suggested by the recent demonstration 
that Kupffer cells produce PAF in response to the 
calcium ionophore A23 187 [26]. 
Although we have provided insight into actions 
of PAF on Kupffer cells, we have not 
demonstrated cause and effect relationships be- 
tween Kupffer cell responses in vitro and responses 
to PAF in perfused livers. We also acknowledge 
that it is difficult to demonstrate that such relation- 
ships are valid, particularly when responses in vivo 
are not mimicked by individual cells. However, it is 
well recognized that changes in [Ca2+]i are an im- 
portant mechanism by which hormones and 
mediators regulate cell function including altera- 
tions in cell shape. Moreover, 45Ca2+ washout 
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studies in perfused livers have suggested the possi- 
ble involvement of increases in Kupffer cell [Ca2+]i 
in the biologic actions of PAF [13]. 
In view of the foregoing evidence, it seems ap- 
propriate to suggest that Kupffer cells play a 
primary role in hemodynamic and metabolic re- 
sponses to PAF in liver. We propose that PAF 
binding to Kupffer cells increases [Ca2+]i resulting 
in hepatic vasoconstriction by alterations in Kupf- 
fer cell shape or ‘sphincter cell’ activity. Hydrolysis 
of inositol lipids by receptor-mediated phospho- 
lipase C activation leads to production of second 
messengers which can increase [Ca2+]i by effects on 
Ca2+ mobilization and/or Ca2+ influx [ 141. While 
we have not defined the mechanisms underlying 
PAF-induced increases in [Ca2+]i in Kupffer cells, 
our results are consistent with a role for inositol 
lipid biosignalling in this process. 
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